Remove Doctors Remove Pharma Remove Pharmaceutical manufacturing
article thumbnail

8 SEO Tips for Pharma Websites

PM360

It’s imperative that pharma businesses understand what their potential customers are searching for when they are typing into search fields. But pharma has had a tendency to shy away from search engine optimization (SEO) strategy; however, for those who do engage with SEO marketing, the rewards can be high.

Pharma 96
article thumbnail

How Patients Can Achieve True Adherence – Two Elements For the Path Forward

Impetus Digital

Everything from finding discounts for expensive medications to figuring out how to get to their many doctor’s appointments; for these patients to succeed, they need a simplification and streamlining of all of this, preferably in one place. Having the right tools, like digital platforms, is a game-changer. Luke received his B.A.

Patients 100
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

MEDICAL ADHERENCE – Tapping Into Provider-Patient Bonds

PM360

This is an achievable reality through strategic use of existing healthcare channels that have been negotiated for pharma access—inside the electronic health record (EHR). They point to an unmissable opportunity for pharmaceutical manufacturers and their media partners to create impact where it matters most—at time of prescribing.

Medical 52
article thumbnail

10 New Solutions, Strategies, and Devices to Boost Adherence

PM360

Doctors, caregivers, life sciences companies, and even companies in other industries have attempted to answer this question for as long as medications have been available. Pharma Manufacturer Solutions. GM of Manufacturer Solutions. How can we help ensure patients continue to take their medications as prescribed?

article thumbnail

Pharmaceutical Patents: A Challenge for Malaysia

Contrarian Sales Techniques

It is noteworthy that Malaysia has a pharmaceutical manufacturing sector that almost exclusively produces generic drugs, with sales revenues amounting to only 1.5% of gross domestic product (GDP). I also note that the five largest companies typically sell originator drugs and account for 47 percent of total drug imports.